Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma

International Journal of Urology - Tập 19 Số 11 - Trang 1017-1025 - 2012
Imke Sanders1, Stefan Holdenrieder2, Gisela Walgenbach‐Brünagel2, Alexander von Ruecker3, Glen Kristiansen3, Stefan C. Müller4, Jörg Ellinger4
1Department of Urology, University Hospital Bonn, Bonn, Germany
2Institute of Clinical Chemistry and Clinical Pharmacology
3Institute of Pathology, University Hospital Bonn, Bonn, Germany
4Department of Urology

Tóm tắt

Objectives:  To identify an appropriate reference gene for the analysis of circulating micro‐ribonucleic acid in patients with urological malignancies.Methods:  Serum from patients with prostate cancer (n = 24), bladder cancer (n = 24), renal cell carcinoma (n = 24) and control subjects (n = 48) was spiked with cel‐miR‐39, and then ribonucleic acid was isolated. Quantitative real‐time polymerase chain reaction was used to determine the levels of candidate reference genes (RNU1‐4, RNU6‐2, SNORD43, SNORD44, SNORD48, SNORA74A, miR‐let‐7a‐1, miR‐106a). Reference gene stability was determined using the NormFinder, geNorm and comparative delta‐Ct algorithm. The effect of normalization was tested with miR‐21 as the target gene, as this was previously suggested to be upregulated in cancer patients' serum.Results:  Recovery of cel‐miR‐39 (mean 11.6%, range 1–56%) was similar in control subjects and cancer patients. SNORD44 and SNORD74A levels were around the detection limit of the assay and were thus omitted. All remaining candidates showed satisfying stability; SNORD43 was the most stable reference gene using all three algorithms. A combination of two genes (SNORD43, RNU1‐4) increases the stability somewhat. The level of miR‐21 was similar in cancer patients and healthy controls, irrespective of the normalization strategy.Conclusions:  SNORD43 is a suitable reference gene for the analysis of circulating micro‐ribonucleic acid in patients with urological malignancies. Our study questions the suitability of miR‐21 as a biomarker for uro‐oncological patients.

Từ khóa


Tài liệu tham khảo

10.1016/S0092-8674(04)00045-5

10.1038/nrc1840

10.1073/pnas.0510565103

10.1038/nature10888

10.1111/j.1365-2141.2008.07077.x

10.1073/pnas.0804549105

10.1373/clinchem.2007.097972

10.1371/journal.pone.0003694

10.1038/cr.2008.282

10.1093/nar/gkq601

10.1093/nar/gkr254

10.1016/j.ab.2011.06.009

10.1186/gb-2002-3-7-research0034

10.1016/j.bbcan.2010.07.002

10.1016/j.urology.2011.01.020

10.3858/emm.2010.42.11.076

10.1016/j.cancergencyto.2010.06.009

Leite KR, 2011, MicroRNA expression profiles in the progression of prostate cancer‐from high‐grade prostate intraepithelial neoplasia to metastasis, Urol. Oncol.

10.1186/1471-2199-9-76

10.1186/1471-2407-10-173

10.1007/s12033-011-9414-6

10.1007/s10620-011-1981-7

10.1186/1471-2199-7-33

10.1158/0008-5472.CAN-04-0496

10.1007/s13277-011-0154-9

10.1373/clinchem.2010.151845

10.1016/j.ejso.2009.04.010

10.1016/j.clinbiochem.2009.07.020

10.1371/journal.pone.0025787

10.1038/sj.bjc.6606076

10.1261/rna.939908

10.1371/journal.pone.0031060

10.1016/j.urology.2009.10.033

10.1158/0008-5472.CAN-08-4043

10.1016/j.bbrc.2011.11.035

10.1002/pros.21246

10.1002/jso.23064

10.1007/s12032-011-9923-y

10.1007/s10549-012-1988-6

10.1007/s10620-010-1285-3

10.1373/clinchem.2011.172767

10.1007/s00277-011-1350-9

10.1038/bjc.2011.198

10.1371/journal.pone.0028486

10.1371/journal.pone.0026971

10.1002/mc.20712

Thông tin
Thông tin xuất bản

International Journal of Urology

Tập 19 Số 11

1017-1025

Thông tin tác giả